Formation of 4-hydroxy-2-nonenalmodified proteins in ischemic rat heart. Am. J. Physiol. 276 (Heart Circ. Physiol. 45): H935-H943, 1999.-4-Hydroxy-2nonenal (HNE) is a major lipid peroxidation product formed during oxidative stress. Because of its reactivity with nucleophilic compounds, particularly metabolites and proteins containing thiol groups, HNE is cytotoxic. The aim of this study was to assess the extent and time course for the formation of HNE-modified proteins during ischemia and ischemia plus reperfusion in isolated rat hearts. With an antibody to HNE-Cys/His/Lys and densitometry of Western blots, we quantified the amount of HNE-protein adduct in the heart. By taking biopsies from single hearts (n ϭ 5) at various times (0, 5, 10, 15, 20, 35, and 40 min) after onset of zero-flow global ischemia, we showed a progressive, time-dependent increase (which peaked after 30 min) in HNE-mediated modification of a discrete number of proteins. In studies with individual hearts (n ϭ 4/group), control aerobic perfusion (70 min) resulted in a very low level (296 arbitrary units) of HNEprotein adduct formation; by contrast, after 30-min ischemia HNE-adduct content increased by Ͼ50-fold (15,356 units, P Ͻ 0.05). In other studies (n ϭ 4/group)
may be the primary targets for free radical damage (22, 31) .
The reactive, short-chain aldehyde trans-4-hydroxy-2-nonenal (HNE) is formed in biological tissues during oxidative stress. It is produced as a result of ␤-cleavage of alkoxy or peroxy radicals. Alkoxy and peroxy radicals are formed from the decomposition of lipid hydroperoxides, which are produced when membrane -6 polyunsaturated fatty acids (e.g., linoleic acid, arachidonic acid, and docosahexaenoic acid) undergo free radicalmediated peroxidation (11, 43) . HNE is also produced as a result of ischemia and reperfusion in many tissues (34) , including the isolated perfused rat heart (4) .
HNE has a considerably longer half-life than free radical species and is capable of inhibiting the function of key enzymes such as glyceraldehyde-3-phosphate dehydrogenase (38) and ion-translocating proteins such as the sodium pump (33) . Indeed, the latter has been proposed as a potential target for oxidation during cardiac reperfusion injury (17, 22) . Protein function is disrupted by HNE because of its reactivity with the amino acids cysteine, histidine, and lysine. Evidence for the potential toxicity of HNE is derived from studies in which isolated rat hearts are perfused with exogenous HNE and show a resulting disturbance of coronary flow (41) , GSH depletion, and contractile impairment (20) . Exposure of the rat left atrium to HNE can result in a reduction of ␤-adrenoceptor function and eventual contractile failure (16) . Because HNE is produced in the heart during oxidative stress and because it disrupts cardiac function, it is possible that at least some component of the myocardial dysfunction that characterizes ischemia and reperfusion might be attributable to the production of endogenous HNE. The location of ion exchangers, pumps, and channels within the lipid environment of the membrane may make them particularly vulnerable to HNE modification because they are close to the lipid environment in which HNE concentration is likely to be highest.
The aim of the present study was to assess the extent to which HNE-modified proteins are produced in the isolated perfused rat heart during ischemia and reperfusion and to see whether this can be attenuated by an antioxidant such as MPG. This study exploits the availability of an antibody produced and characterized by Uchida et al. (39) . This antibody is specific for proteins containing adducts of HNE coupled to cysteine, histidine, or lysine and has been used previously with Western immunoblotting to assess HNE protein modification in hepatocytes (39) and of glyceraldehyde-3-phosphate dehydrogenase (38) . This anti-HNE antibody has also been used for immunohistochemical demonstration of the accumulation of HNE-modified proteins in atherosclerotic lesions (37) .
MATERIALS AND METHODS

Animals.
Male Wistar rats (200-250 g, obtained from BK Universal) were used throughout this study. The rats were maintained humanely and in compliance with the ''Principles of Laboratory Animal Care'' formulated by the National Society for Medical Research and the Guide for the Care and Use of Laboratory Animals prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication no. 85-23, revised 1985) .
Isolated heart preparations. Animals were anesthetized with diethyl ether and injected with 200 IU of sodium heparin via the femoral vein. Hearts were rapidly excised and placed in cold (4°C) bicarbonate buffer, and the aorta was cannulated. The hearts were then perfused with bicarbonate buffer gassed with 95% O 2 -5% CO 2 Perfusion protocols. The perfusion protocols used in this study are summarized in Fig. 1 . All hearts were subjected to an initial period of 20 min of aerobic perfusion. Global zero-flow ischemia was achieved by terminating perfusion. During ischemia, hearts were maintained in a thermostatically controlled chamber filled with bicarbonate buffer at 37°C. In protocol I, biopsies (ϳ20-mg wet wt) were cut from the left ventricle of ischemic hearts (n ϭ 5) every 5 min up to a total duration of 40 min. Protocol II was designed to assess the effect of reperfusion (20 min) after 30 min of ischemia on HNE-induced protein modification. Because in the rat heart 30 min of ischemia may result in a mixture of stunned and lethally injured cells, shorter, sublethal periods of ischemia were used in protocol III to allow any additive effects of reperfusion to be revealed. The preischemic administration of the antioxidant N-(2-mercaptopropionyl)glycine (MPG) was examined in protocols IV and V. Antioxidant solutions were prepared immediately before use by dissolving MPG to a final concentration of 1 mM in bicarbonate buffer. Hearts were perfused with this solution during the last 5 min of the initial aerobic period. In all protocols (except protocol I, in which biopsies were taken) four hearts were used per treatment group.
Protein analysis. Cardiac protein was prepared by grinding tissue under liquid nitrogen and then boiling the powder in SDS sample buffer (23) . SDS-PAGE was carried out using the Bio-Rad mini protean II system on 10% polyacrylamide gel with 30 µg of protein loaded per lane.
After electrophoresis, samples were transferred to nitrocellulose (Amersham) using a Pharmacia system semidry blotter. An antibody to HNE-Cys/His/Lys (generously donated by Dr. K. Uchida) was used to detect the HNE-modified proteins. An anti-rabbit secondary antibody coupled to horseradish peroxidase (Amersham) was used with enhanced chemiluminescence reagent (ECL, Amersham) to visualize primary antibody binding. Western blots were digitized using a flatbed scanner (HP Scanjet 11C). The digitized image was then quantitatively analyzed for HNE-modified proteins using NIH Image software (freeware, National Institutes of Health, Bethesda, MD). No single protein was selected for analysis, but the density of staining in each lane was assessed as a whole. This provides a single value representing the integrated density of all of the different protein adducts formed within that lane.
Immunofluorescence. Four perfusion sequences (shown in Fig. 1 , protocol V) were used in the immunofluorescent localization of HNE-modified proteins. In this study, ischemic duration was limited to 20 min to minimize irreversible structural damage to the myocardium that might distort tissue architecture and complicate the immunohistochemical localization. Hearts were snap-frozen using liquid nitrogen and isopentane, and left ventricular tissue was cryosectioned into 6-µm sequential sections. Pretreatment of sections and immunofluorescence was carried out as previously described (25) . Normal rabbit IgG (5 µg/ml) was used in each experiment as a negative control. The specific antibody binding was detected using FITC-conjugated goat anti-rabbit IgG (Sigma Chemical). Specific fluorescent staining of cardiac tissue was identified under ultraviolet light with an Olympus BH2-RFCA microscope using an oil-immersion lens (magnification ϫ40) and photographed. Three sections from each heart were analyzed, and two different hearts were used for each experiment.
Statistics. Results are presented as means Ϯ SE. Differences between groups were assessed using ANOVA, followed by a t-test. Differences were considered significant at the 95% confidence level. Fig. 2 demonstrates that ischemia induces an HNEmediated, time-dependent modification of proteins in the isolated rat heart (protocol I). Each lane on the blot represents a sample from a single heart. Modification of proteins by HNE was first detectable after 5 min of ischemia and then progressively increased to reach a maximum after ϳ30 min. No further increase in HNE signal intensity was apparent when ischemia was extended beyond 30 min. The antibody used in these experiments recognizes all proteins containing adducts of HNE coupled to cysteine, histidine, or lysine. It is interesting to note that of the many thousands of proteins present in these whole heart homogenates, only a small number of discrete bands can be identified, suggesting that only a relatively small number of proteins (12) appear to be susceptible to modification by HNE.
RESULTS
Effect of ischemia on HNE-protein adduct content of isolated perfused hearts. The Western blot shown in
Time course for appearance of HNE-protein adduct content in biopsy samples. Figure 3 quantifies, via digitization of Western blots (including the one shown in Fig. 2 ) probed with the anti-HNE antibody, the time-dependent HNE modifications that occur in the heart during ischemia. This was achieved by taking biopsies from five different hearts every 5 min during ischemia (protocol I). The graph shows a time-dependent increase in HNE-modified protein in the biopsy samples during ischemia, which reached a maximum after 30 min. The profile of HNE modification of cardiac proteins during ischemia is sigmoidal with a half-time of maximal HNE-adduct formation of 18 min. It is important to note that the extent of protein adduct formation after various durations of ischemia was not influenced by the biopsy procedure and was quantitatively comparable whether measured in the biopsy samples (protocol I) or in whole heart homogenates (protocols II-V).
Effect of reperfusion on HNE-protein content in isolated perfused hearts. Figure 4 illustrates the HNEprotein content of the heart after 1) 70-min aerobic perfusion (control), 2) 30-min ischemia, and 3) 30-min ischemia plus 20-min reperfusion as described in protocol II (Fig. 1 ). It is evident that there is very little HNE-protein adduct produced during 70-min aerobic perfusion (296 arbitrary units) but substantial production after 20-min aerobic perfusion plus 30-min ischemia (15,356 units) . It is also evident that 20 min of reperfusion after 30-min ischemia does not further increase the HNE-protein content over and above that achieved during the 30-min ischemic period alone.
Effect of short periods of ischemia with or without reperfusion on HNE-protein content of isolated perfused heart. Because it is generally assumed that it is during reperfusion that the heart may be subjected to the major oxidant stress, the lack of further HNE-adduct formation on reperfusion was surprising. We therefore investigated whether the lack of further adduct formation during reperfusion was caused by the ''saturation'' of the system by the cumulative stresses involved in the relatively long 30-min ischemic period (see Fig. 3 ). This was undertaken by investigating the effects of shorter periods of ischemia (5, 10, and 15 min), in which the ischemia-induced HNE adduct formation should be submaximal, with or without 20-min reperfusion (see protocol III, Fig. 1 ). Figure 5 confirms the timedependent increase in HNE-protein adduct production with increasing durations of ischemia. It also shows that, even after short periods of ischemia, reperfusion does not further increase the production of the HNE adducts. Figure 6 shows that the antioxidant MPG (1 mM given 5 min before the onset of ischemia, see protocol IV, Fig. 1 ) reduced, by ϳ75%, the formation of HNE-modified proteins during 30-min ischemia. This MPG-mediated attenuation in HNE-protein adduct formation during 30-min ischemia was unchanged by 20-min reperfusion in the absence of MPG and by 20-min reperfusion in the presence of MPG.
Immunolocalization of HNE-protein adducts. Figure  7 shows immunohistochemical localization of HNEmodified proteins in heart cryosections. It is evident that ischemia (Fig. 7B ) caused a major increase in HNE signal compared with control aerobic tissue (Fig. 7A) . The majority of the HNE adduct signal was localized in the cell membrane with little change in nonspecific labeling. Some intracellular localization was also noted, possibly associated with the myofilaments. Reperfusion (20 min, Fig. 7C ) resulted in a slight decline in the HNE signal compared with that from the ischemic heart. Sections from the heart made ischemic in the presence of MPG (Fig. 7D ) showed a marked attenuation in the formation of HNE-modified proteins.
These immunohistochemical data demonstrate the same treatment effects as those revealed quantitatively by Western blot analysis. Additionally, they show that the increased HNE signal induced by ischemia is largely associated with the sarcolemma. Ischemia also induces some immunofluorescent labeling within the Fig. 5 . Effect of reperfusion on HNE-protein adduct formation after short (5, 10, or 15 min) periods of ischemia (protocol III). Hearts were homogenized either at end of ischemia or after 20-min reperfusion. Data are plotted as means Ϯ SE. There were no differences between ischemic and reperfusion samples at any given ischemic duration (ns). cells. This labeling may be associated with the myofilaments, although the resolution does not allow for an absolute identification of its intracellular location.
DISCUSSION
Ischemia and HNE-protein adduct formation in isolated perfused hearts.
Our studies demonstrate that in the isolated perfused rat heart, ischemia leads to the modification of proteins by the highly reactive lipid peroxidation product HNE. Because HNE can only be formed by the interaction of free radicals with lipids (11), it can be concluded that ischemia promotes the formation of free radicals that, in turn, lead to structural modifications of cardiac proteins. Because protein modification of this type can lead to loss of function (33, 38) , this cytotoxic metabolite might represent a further factor that contributes to the loss of cellular homeostasis during ischemia. The concept that HNE may induce detrimental modifications of critical membrane proteins during ischemia is supported by reports that mechanical and electrical dysfunction can be induced by the exogenous application of pathophysiologically relevant concentrations of HNE (3, 16) .
Time course of HNE protein modification. The present studies have shown that the HNE protein modifications occur in a time-dependent manner during the first 30 min of ischemia. It is possible that the time course of HNE protein modification is directly related to the rate of ischemia-induced antioxidant depletion and/or free radical production. In this connection, there is evidence in the literature for antioxidant depletion (10) and free radical formation (26, 28, 35) in the heart during a similar ischemic duration. In particular, the concentration of GSH in the heart falls rapidly and substantially within minutes of the onset of ischemia. Because GSH is a major cellular antioxidant and scavenger of free radicals, its loss may well leave the heart vulnerable to lipid peroxidation, HNE formation, and protein modification. Because GSH can also scavenge reactive, electrophilic cytotoxins such as HNE directly, its depletion may further promote the damaging effects. The enzymatic coupling of GSH to HNE is also an efficient detoxification mechanism in the heart (20, 21) that might be compromised during ischemia. It is therefore possible that the modifications of proteins by HNE during ischemia may occur as an indirect consequence of the fall in GSH concentration that accompanies ischemia. This loss of GSH during ischemia occurs because the biochemical pathway required to reduce GSSG and restore GSH is dependent on ATP, which itself becomes depleted during the first 30 min of severe ischemia (45) . Depletion of the myocardial pool of GSH has been suggested to diminish the ability of the heart to recover from ischemia (44) , even if the ischemic duration is short (6) . Additionally, it has been shown that the GSH status of the heart is critical for the recovery of contractile function during reperfusion (8, 9) . Our studies now raise the possibility that the loss of GSH during ischemia may compromise survival and recovery because of the loss of ability to limit the accumulation of cytotoxic species such as HNE that are then able to damage key cellular proteins.
Reperfusion and HNE-protein adducts. Surprisingly, our results indicate that HNE-mediated modifications that occur during ischemia are neither reversed nor exacerbated by reperfusion and that reperfusion has little or no effect on the HNE-protein content of the heart. The failure of reperfusion to reduce the tissue content of HNE-protein adducts formed during ischemia might be explained by the findings of Friguet et al. (12) , who demonstrated that HNE-modified proteins are not degraded at any greater rate than native proteins and therefore could persist in tissue for some time. Although reperfusion failed to reduce tissue HNEprotein adduct content, it might have been expected to increase the content, because reperfusion is associated with a burst of oxidant stress that might be expected to promote further protein modification. In this connection, Blasig et al. (4) claimed that reperfusion resulted in increased ''free'' HNE release into the coronary effluent of perfused rat hearts. Although at first sight this might support the concept of increased HNE production during reperfusion, it is important to note that Blasig et al. did not measure HNE production during ischemia, and therefore the peak of HNE release observed during reperfusion may simply reflect the washout of HNE accumulated during the preceding ischemia.
Saturation of HNE-protein adduct production? As discussed in Reperfusion and HNE-protein adducts, reperfusion is known to be associated with increased free radical production (5, 14, 29) and oxidant stress. It was therefore surprising that it was during ischemia and not reperfusion that the HNE-protein modifications occurred. The rapid depletion of cellular antioxidants during ischemia may, however, leave the cell vulnerable to a low level of oxidant stress that persists during ischemia. This may lead to a relatively rapid saturation of all of the available sites for HNE modification. This would be consistent with our observation that HNE-protein adduct formation appears to saturate after ϳ30 min of ischemia ( Fig. 3) . To test whether the saturation of available HNE-modifiable sites occurs and effectively masks any reperfusion-induced HNEprotein adduct production, we undertook experiments with reperfusion after short periods of ischemia. After ischemic durations in which adduct formation was not saturated, however, reperfusion induced no further HNE-protein adduct production.
The lack of a reperfusion-induced increase in HNEprotein adduct formation may be explained by the effects of the restoration of coronary flow on cellular HNE extrusion. Under aerobic conditions, HNE is sequestered by reduced GSH and is then exported from the cell via the cardiac GSSG/S-conjugate transporter (20, 21) . The functional efficiency of this transport system is dependent on the maintenance of an outward concentration gradient normally maintained by the washout of these exported GSH conjugates in the venous effluent. During ischemia, when flow is arrested, the export of GSH conjugates of HNE may be H940 HNE-PROTEIN ADDUCTS IN ISCHEMIA limited as the concentration gradient is dissipated. The resulting higher intracellular concentration of GSHconjugated HNE during ischemia may then reduce the spontaneous reaction of HNE with GSH, as well as the enzymic coupling of GSH to HNE, by end-product inhibition of these two detoxifying reactions. This may lead to an elevated intracellular concentration of free HNE, which is then able to react with cardiac proteins. On reperfusion, when coronary flow is reinitiated, the concentration gradient will be rapidly reestablished and the intracellular HNE detoxification mechanisms reactivated. This may explain why reperfusion does not enhance HNE-protein adduct formation and would suggest that oxidant stress-mediated reperfusion injury (such as myocardial stunning), which occurs in the early seconds and minutes of reperfusion, may involve the direct interaction of free radicals with cardiac proteins rather than lipid peroxidation reactions. Electrophysiological evidence suggests that the rapidity of free radical-induced disturbances during reperfusion is likely to involve the direct oxidation of protein thiols rather than the slower process of lipid peroxidation (31) .
It is generally accepted that it is oxidant stress during reperfusion, rather than ischemia, that is the most damaging to the heart (5, 7, 14, 46) . However, when many of the studies that report this effect are critically assessed, it is apparent that the experimental methods used do not allow the measurement of free radicals during ischemia. For example ''spin trapping'' agents are included in the perfusate that react with radicals to form stable adducts. However, during zeroflow ischemia, the cessation of flow means that such adducts are trapped in the heart only to appear during the early moments of reperfusion. Where methods have been used that allow direct measurement in the ischemic heart, free radical production has been reported during ischemia (1, 15, 26, 28, 35, 36) . Indeed, Maupoil et al. (26) and Timoshin et al. (36) reported a decrease in free radical production on reperfusion. With the use of isolated myocytes and probes that fluoresce on interaction with free radicals, significant radical production was recently demonstrated during simulated ischemia, with an additional burst of production during reperfusion (40) . Thus our observation that HNEmodified proteins are produced during ischemia is consistent with previous reports that a significant oxidant stress occurs during ischemia before reperfusion.
MPG and HNE-protein adduct content. Because HNE is a free radical end product that freely reacts with sulfydryl-containing compounds, we investigated the ability of the thiol-containing antioxidant MPG to inhibit the formation of HNE-modified proteins. MPG was particularly effective at inhibiting the production of the HNE-protein adducts. The efficacy of MPG may be related to its ability to terminate free radical chain reactions and/or to directly sequester free HNE. Previous studies showed that MPG (24, 27) , as well as other antioxidants (19, 30) , can protect the ischemic-reperfused heart. In light of our results, it is possible that the protective effects of antioxidants, when administered before ischemia and reperfusion, may involve limiting the generation of the reactive lipid peroxidation product HNE or scavenging HNE after its production during ischemia.
Immunolocalization of HNE-protein adducts. In the present studies, subcellular immunohistochemical analysis of cryosections showed that 20 min of ischemia resulted in a large increase in binding of the anti-HNE antibody. The HNE concentration at its site of production, the lipid membrane, may be particularly high [concentrations of 4-10 mM were reported by Benedetti et al. (2) ], and, consequently, membrane-associated proteins may be particularly susceptible to modification. The increased HNE immunofluorescence observed during ischemia was primarily localized to the sarcolemma, suggesting that the membrane is indeed the major site of formation of HNE-modified proteins. The HNE-reactive amino acids (cysteine, histidine, and lysine) are often critical in the functional mechanism of ion transporters, and thus modification of these groups by HNE may have detrimental effects on ion homeostasis. The localization of the HNEprotein immunostaining to the plasma membrane provides additional evidence for the hypothesis that oxidant stress in the heart results in the dysfunction of important cardiac ion-translocating proteins (17, 18) . Indeed, it has been shown in myocytes that a key ion translocator, the Na ϩ -K ϩ pump, is particularly susceptible to oxidant stress (17, 31, 32) and that this protein can be directly modified by HNE, resulting in pump inactivation (2) . HNE immunofluorescence from ischemic heart sections also showed longitudinal striations with possible colocalization with the myofibrils, suggesting possible modification of contractile proteins. Considerable evidence now suggests that the myofilaments may also be an important target for oxidant stress during ischemia-reperfusion (13, 42) , and thus myofilament dysfunction may be related to the formation of HNE adducts with key contractile proteins.
Sections taken from hearts made ischemic and then reperfused exhibited slightly less HNE-protein immunofluorescence than sections from ischemic hearts. This observation contrasts with the Western blot data, which demonstrate no quantitative difference between the HNE-protein adduct content of ischemic and ischemic-reperfused hearts. This apparent attenuation in HNE immunofluorescence during reperfusion may be associated with a loss in the structural integrity of the cardiac cells that can accompany ischemia and reperfusion as a result of cellular disruption and cytoskeletal damage resulting in a more diffuse pattern of staining. The HNE immunofluorescence results for ischemic hearts pretreated with MPG are in agreement with the Western blot data in that the protein-HNE signal was attenuated when MPG was present during the ischemic period, and, again, this is likely to reflect the ability of MPG to stop radical chain reactions that initiate HNE production and to sequester free HNE, which can otherwise lead to the formation of protein adducts.
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This study demonstrates that ischemia results in structural modifications to cardiac proteins that are not reversed during early reperfusion. Two key questions, however, remain unanswered: 1) Which proteins are modified by HNE during ischemia? 2) Do the structural modifications of proteins by HNE contribute to functional changes that adversely affect cardiac performance during reperfusion? Our observation that only a relatively small discrete number of proteins form adducts with HNE would make the identification of these proteins feasible. Once vulnerable proteins have been identified, their function could be individually assessed under control and HNE-conjugated conditions. In this way the contribution of this process of oxidative modification of proteins during ischemia could be assessed.
